[BREAKING] Trump announces 100% tariff on branded or patented pharmaceutical imports from Oct 1

stanlawj

Supremacy Member
Joined
Jul 11, 2021
Messages
9,130
Reaction score
4,906
Guys, this is our dream. It is the end the Singapore's model of economy on MNC outsourcing.
Kill the cancerous goose in the Singapore economy.
For the first time, now the Singapore govt needs to rethink their policies on manpower and education. If not for Trump, the current leaders will just sit on their asses and continue with their reliance on MNC outsourcing to Singapore.
 

titusilvering

Banned
Joined
May 16, 2010
Messages
37,120
Reaction score
17,358
https://www.channelnewsasia.com/wor...s-us-trucks-furniture-home-renovation-5370396

Trump announces 100% tariff on branded or patented pharmaceutical imports from Oct 1​

The US president also announced new tariffs on trucks, home renovation fixtures and furniture.

WASHINGTON: United States President Donald Trump announced on Thursday (Sep 25) new tariffs on pharmaceuticals, big-rig trucks, home renovation fixtures and furniture.

Starting Oct 1 "we will be imposing a 100 per cent Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America," the Republican wrote on his Truth Social platform.

In a separate post, he wrote of a 25 per cent tariff on "all 'Heavy (Big) Trucks' made in other parts of the world" to support US manufacturers such as "Peterbilt, Kenworth, Freightliner, Mack Trucks and others".

He said the truck tariffs were "for many reasons, but above all else, for National Security purposes!"

Earlier this year, the Trump administration launched a probe into imports of trucks to "determine the effects of national security".

The real estate tycoon also targeted home renovation materials, writing "We will be imposing a 50 per cent Tariff on all Kitchen Cabinets, Bathroom Vanities and associated products" as of Oct 1.

"Additionally, we will be charging a 30 per cent Tariff on Upholstered Furniture," he added.
Tiongkok jialat. India jialat. But then he should 200%
 

Ubi-Warrior

High Supremacy Member
Joined
Jan 29, 2020
Messages
34,031
Reaction score
7,735
Guys, this is our dream. It is the end the Singapore's model of economy on MNC outsourcing.
Kill the cancerous goose in the Singapore economy.
For the first time, now the Singapore govt needs to rethink their policies on manpower and education.

Havent they actively been supporting local industry?

Should have just stuck to services you think?
 

lifeisinforashock

High Supremacy Member
Joined
Jan 22, 2008
Messages
43,448
Reaction score
5,783
Oh no, all the pharma plants in Spore need to close and resettle back in US

Where's the Task Force Man?

I think most pharma coys their manufacturing is in india bah, here sg mayb the warehousing for subsequent export.
 

thyler_koh

Supremacy Member
Joined
Mar 10, 2001
Messages
7,900
Reaction score
3,828
Oh no, all the pharma plants in Spore need to close and resettle back in US

Where's the Task Force Man?
Oh , don’t worry . his PA is already booking business class ticket so that he will fly there and come back to say , there is nothing can be done .
 

Joe Maya

High Supremacy Member
Joined
Feb 29, 2016
Messages
35,495
Reaction score
12,253

Key Pharmaceutical Companies in Singapore Potentially Affected​


  1. Pfizer
    • Presence: Pfizer has a significant manufacturing presence in Singapore, with a 429,000-square-foot plant in Tuas Biomedical Park producing active pharmaceutical ingredients (APIs) for cancer, pain, and antibiotic medications. It established its presence in Singapore in 1964 and is a top pharmaceutical manufacturer there [Built In Singapore, 2024-09-20].
    • Impact: Pfizer exports APIs and finished drugs to the U.S., which is one of its major markets. The tariff could pressure Pfizer to either accelerate or initiate new U.S.-based manufacturing to avoid the 100% levy, potentially reducing its reliance on Singapore for U.S.-bound production. Given its existing global supply chain, Pfizer might already have U.S. facilities, but any Singapore-produced branded drugs (e.g., those under patents like anti-infectives) could face tariffs unless construction of a new U.S. plant has started by the deadline.
  2. AstraZeneca
    • Presence: AstraZeneca is building a $1.5 billion manufacturing facility in Singapore for antibody-drug conjugates (ADCs), a category of cancer-killing drugs, with operations expected to begin in 2029. This will be its first end-to-end ADC production site [Reuters, 2024-05-20].
    • Impact: While the Singapore facility is under construction (qualifying it for a tariff exemption under the "IS BUILDING" definition of "breaking ground" or "under construction"), any branded or patented drugs currently exported from Singapore to the U.S. (e.g., existing products like Enhertu, manufactured by partner Daiichi Sankyo in Japan but distributed globally) could face tariffs unless U.S. manufacturing is underway. AstraZeneca may need to expedite U.S. plant construction to maintain its U.S. market share for other products.
  3. Amgen
    • Presence: Amgen opened its first Asian manufacturing facility in Singapore in 2014 and a commercial chemical synthesis plant in 2015. Singapore serves as its Asia Pacific regional headquarters [Built In Singapore, 2024-09-20].
    • Impact: Amgen exports biologic therapies (e.g., Enbreal for autoimmune diseases and Repatha for cholesterol management) to the U.S. The tariff could affect these branded products unless Amgen has or starts building U.S. manufacturing plants. Given its U.S. base (California), Amgen may already have domestic production, but Singapore-made exports could be at risk.
  4. Eli Lilly
    • Presence: Eli Lilly has a significant presence in Singapore, handling wholesale distribution of prescription and proprietary drugs across the Asia Pacific region. It develops compounds for over 40 disease areas [Built In Singapore, 2024-09-20].
    • Impact: Eli Lilly exports branded drugs like Mounjaro (for diabetes and weight loss) and Cialis to the U.S. If these are manufactured in Singapore or other non-U.S. locations, the 100% tariff will apply unless U.S. plant construction begins. Lilly, based in Indiana, likely has U.S. facilities, but Singapore’s role in distribution and potential manufacturing could be affected if production shifts.
  5. Bayer
    • Presence: Bayer’s Singapore office serves as the regional headquarters for the Asia Pacific market, covering pharmaceuticals, crop science, and consumer health. It produces drugs like Aspirin and Claritin [Built In Singapore, 2024-09-20].
    • Impact: Bayer exports branded pharmaceuticals and over-the-counter products to the U.S. The tariff could impact Singapore-produced branded drugs unless Bayer initiates U.S. manufacturing. As a German company, Bayer has global facilities, but Singapore’s export role may diminish if it prioritizes U.S. production to avoid the tariff.
  6. Schwabe Pharma Asia Pacific
    • Presence: A subsidiary of the Schwabe Group, it focuses on homeopathic and herbal medicines, operating out of Singapore since 2005 [Built In Singapore, 2024-09-20].
    • Impact: If Schwabe exports patented or branded herbal medicines to the U.S. from Singapore, it could face the tariff. As a niche player, its ability to build a U.S. plant may be limited, potentially forcing it to redirect exports or absorb the cost increase.
  7. APD Pharmaceutical Manufacturing Pte Ltd
    • Presence: A GMP-certified contract manufacturer in Singapore with 16+ years of experience, offering private-label products and one-stop services including product development and registration [apd.com.sg, 2025-04-16].
    • Impact: APD manufactures for other companies and could be affected if its clients export branded or patented drugs to the U.S. The tariff might push APD’s partners to shift production to the U.S., reducing demand for Singapore-based contract manufacturing unless APD itself invests in U.S. facilities (unlikely given its scale).

Broader Considerations​

  • Export Dependency: Singapore exports more pharmaceuticals than it imports, with the U.S., Europe, and Japan as key markets. The tariff could disrupt this balance, especially since U.S. demand for APIs and drugs surged during the pandemic [Reuters, 2020-05-27].
  • Construction Exemption: Companies with plants "under construction" in the U.S. by October 1, 2025, are exempt. Firms like AstraZeneca (with its Singapore plant) may leverage this, but others must act quickly to start U.S. projects.
  • Market Response: The Monetary Authority of Singapore has highlighted that 40% of U.S.-bound exports (including drugs) are at risk, suggesting a potential shift in global supply chains [Reuters, 2025-04-28]. Companies may relocate production or raise prices, impacting Singapore’s biomedical sector, which employs 24,000+ people [Reuters, 2020-05-27].

Likely Affected Companies​

The most affected companies will be those with significant U.S. exports of branded or patented drugs from Singapore without current or planned U.S. manufacturing. Pfizer, Amgen, Eli Lilly, and Bayer are particularly vulnerable due to their large-scale operations and U.S. market presence. AstraZeneca may be partially shielded by its ongoing U.S. expansion plans, while smaller players like Schwabe Pharma and APD could face indirect pressure through client decisions.


Recommendation​

These companies should assess their U.S. manufacturing status and consider initiating construction by the deadline to avoid the tariff. Alternatively, they might redirect exports to other markets (e.g., Europe, Japan) or negotiate with the U.S. government for exemptions, though the latter seems unlikely based on the firm stance in the announcement. Monitoring updates from the White House and U.S. trade policy will be critical in the coming weeks.


U use chatgpt is it.
 

PrinceY

Supremacy Member
Joined
May 11, 2015
Messages
7,889
Reaction score
3,013
Kick off so fast? this one cannot strike deal ah? need to form another task force bo?
 
Important Forum Advisory Note
This forum is moderated by volunteer moderators who will react only to members' feedback on posts. Moderators are not employees or representatives of HWZ Forums. Forum members and moderators are responsible for their own posts. Please refer to our Community Guidelines and Standards and Terms and Conditions for more information.
Top